Metformin vs Insulin in the Management of Gestational Diabetes: A Meta-Analysis
Open Access
- 27 May 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (5), e64585
- https://doi.org/10.1371/journal.pone.0064585
Abstract
Nowadays, there have been increasing studies comparing metformin with insulin. But the use of metformin in pregnant women is still controversial, therefore, we aim to examine the efficiency and safety of metformin by conducting a meta-analysis of randomized controlled trials (RCTs) comparing the effects of metformin with insulin on glycemic control, maternal and neonatal outcomes in gestational diabetes mellitus (GDM). We used the key words “gestational diabetes” in combination with “metformin” and searched the databases including Pubmed, the Cochrane Library, Web of knowledge, and Clinical Trial Registries. A random-effects model was used to compute the summary risk estimates. Meta-analysis of 5 RCTs involving 1270 participants detected that average weight gains after enrollment were much lower in the metformin group (n = 1006, P = 0.003, SMD = −0.47, 95%CI [−0.77 to −0.16]); average gestational ages at delivery were significantly lower in the metformin group (n = 1270, P = 0.02, SMD = −0.14, 95%CI [−0.25 to −0.03]); incidence of preterm birth was significantly more in metformin group (n = 1110, P = 0.01, OR = 1.74, 95%CI [1.13 to 2.68]); the incidence of pregnancy induced hypertension was significantly less in the metformin group (n = 1110, P = 0.02, OR = 0.52, 95%CI [0.30 to 0.90]). The fasting blood sugar levels of OGTT were significantly lower in the metformin only group than in the supplemental insulin group (n = 478, P = 0.0006, SMD = −0.83, 95%CI [−1.31 to −0.36]). Metformin is comparable with insulin in glycemic control and neonatal outcomes. It might be more suitable for women with mild GDM. This meta-analysis also provides some significant benefits and risks of the use of metformin in GDM and help to inform further development of management guidelines.Keywords
This publication has 36 references indexed in Scilit:
- Cellular and molecular mechanisms of metformin: an overviewClinical Science, 2011
- Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)Diabetes Care, 2011
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2011
- Oral hypoglycemic agents for gestational diabetes mellitus?Expert Opinion on Drug Safety, 2010
- International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in PregnancyDiabetes Care, 2010
- Glycemia and Its Relationship to Outcomes in the Metformin in Gestational Diabetes TrialDiabetes Care, 2009
- Standards of Medical Care in Diabetes—2009Diabetes Care, 2009
- Comparison of Metformin and Insulin in the Treatment of Gestational Diabetes: A Retrospective, Case-Control StudyThe Review of Diabetic Studies, 2008
- A Trial in Progress: Gestational DiabetesDiabetes Care, 2007
- Transfer of metformin across the dually perfused human placental lobuleAmerican Journal of Obstetrics and Gynecology, 2006